Sarissa Capital Management LP Vor Biopharma Inc. Transaction History
Sarissa Capital Management LP
- $366 Million
- Q1 2025
A detailed history of Sarissa Capital Management LP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Sarissa Capital Management LP holds 508,016 shares of VOR stock, worth $91,442. This represents 0.1% of its overall portfolio holdings.
Number of Shares
508,016
Previous 618,000
17.8%
Holding current value
$91,442
Previous $685,000
46.72%
% of portfolio
0.1%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding VOR
# of Institutions
46Shares Held
54.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA39.6MShares$7.14 Million0.59% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$1.15 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$349,2400.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$193,4380.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny701KShares$126,2570.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $6.85M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...